Sign in

CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851763759
Phone
919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change · Regulation FD disclosure
  8. 4 Open-market buy Director bought 10,000 shares at $0.56 ($5,620)
  9. 25-NSE Other Notification of Removal from Listing
  10. 4 Open-market buy Director bought 10,000 shares at $0.69 ($6,930)
  11. 4 Open-market buy Director bought 30,000 shares at $0.59 ($17,820)
  12. SCHEDULE 13D/A Stake Beneficial Ownership Report
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Delisting notice
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13D/A Stake Beneficial Ownership Report
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. 4 Derivatives Options or other derivatives

Page 1 of 26 · 506 filings